Table 2.
Comparison of study parameters (control group vs. CKD+HD).
| Variables | Control | CKD+HD | P-value |
| BP (mean ± SD) Systolic Diastolic Mean | 118.94 ± 10.6 72.76 ± 7.50 88.15 ± 7.67 | 129.68 ± 19.50 77.64 ± 12.56 94.99 ± 13.95 | 0.000 0.024 0.002 |
| Hemoglobin (g/dL) | 14.00 ± 1.24 | 12.92 ± 2.06 | 0.002 |
| Albumin (g/dL) | 4.30 ± 0.22 | 4.1 ± 0.48 | 0.001 |
| HDL (mg/dL) | 48.54 ± 9.42 | 42.1 ± 11.05 | 0.001 |
| CRP (mg/L) | 3.18 ± 2.39 | 9.07 ± 16.00 | 0.026 |
| Glucose (mg/dL) | 90 ± 9 | 115 ± 51 | 0.000 |
| Uric acid (mg/dL) | 5.13 ± 1.23 | 6.55 ± 1.64 | 0.000 |
| FMD (%) | 13.24 ± 6.34 | 4.46 ± 3.65 | 0.000 |
| YKL-40 (ng/mL) | 31.73 ± 21.12 | 61.68 ± 24.72 | 0.000 |
BP: Blood pressure, HDL: high-density lipoprotein, CRP: C-reactive protein, FMD: flowmediated dilatation, CKD: chronic kidney disease (stages 2–5, nondialysis), HD: hemodialysis.